🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our SCALLOP consortium work on the genetics of neuro-related proteins is finally published in Nature Human Behaviour Thanks to the 1st authors Linda Repetto ZhiJian Yang Jiantao Chen Ranran for their hard work and of course all the consortium contributors to this effort!

Great example why genetic risk scores should be communicated as both relative and absolute risks. "Highly increased" can mean wildly different things. Knowing both helps.

Today, I'm announcing that Nucleus Genomics is considering the possibility of making a public offer to acquire 23andMe, contingent on financing, as well as initiating and executing a successful negotiation. Our goal would be simple: Revitalize consumer health care with rapid

The GenoPred Pipeline: A Comprehensive and Scalable Pipeline for Polygenic Scoring from Oliver Pain is now online. Github & manual: opain.github.io/GenoPred/ Video: youtube.com/watch?v=dKiG8U… academic.oup.com/bioinformatics…… One-step polygenic score calculations NIHR Maudsley Biomedical Research Centre (BRC)

Impressive study. Such a clear example of why WGS is superior to both exome-seq and array. Bet this will play out for complex disease as well.

What do Nucleus Genomics engineers do in between shipping new features? Well:

New results, ready to view now in your Nucleus portal

Excited to share our new Genome-wide meta-analysis of myasthenia gravis! The study identifies novel genetic loci and enhances prediction models. Read more: nature.com/articles/s4146… Alice Braun #Genetics #MyastheniaGravis

I really liked this commentary. It adresses the circularities in automated variant curation, but also seeks solutions. And I obviously also liked it, because it notes that we still should go beyond that simplistic "yes"/"no" bad pathogenic, good benign approach.

How well do the masses know science? Nucleus Genomics stormed the streets of SoHo for a brand new series to find out. The rules were simple. But we couldn’t have predicted what would happen next…

No reason science communication can't be fun!😁

I’m beyond excited to announce our $14 million Series A with participation from Founders Fund, Seven Seven Six 7️⃣7️⃣6️⃣, Neo, Balaji, Giant Step Capital, One Eight Capital and many others. We’re going to make preventable diseases a thing of the past. 🧵 mynucleus.com/articles/fundr…

Rare genetic diseases are important too....! Please support my fundraiser for Neurofibromatosis research, my.cupids.org/fundraiser/602… (and come cheer tm if you're in NYC)

Today we're launching our new family product. Family means a lot to me, and working on this has been one of the most meaningful projects I've been involved in a while. One insight I felt I got from it was how far ahead the technological possibilities can be in comparison with

These new recommendations align well with how I see the field evolving. Great to see more openness to different sources of genetic data—under proper responsibility, of course! No one wants wrong results. I do see a future where both hospital-initiated and commercial DNA testing

The next chapter of preventative health is here

One year ago, we launched Nucleus with a simple vision: Anyone, anywhere, should have access to their genetic data to make better decisions about their health and future family. Today, we celebrate our first anniversary - but we’re just getting started. Later this week, we're